Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Dynamics of Motivational Factors for Physical Activity and Nutrition in Oncogeriatrics

NCT06445140 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2024-06-18
Last updated
2026-03-12

Condition(s) studied

Cancer

Investigational drug(s) / intervention(s)

Collecting the variables and Implementation of a behavioural intervention

Collecting the variables and Implementation of a behavioural intervention: The observational phase (during 15 days) * Two measurements per day for motivational variables and physical activity and nutrition * Two measurements per day for nutrition * Three measurements per day for fatigue * Continuous PA measurement by accelerometer The interventional phase : Part A (during 7 days) * measuring physical activity (PA) * complete questionnaires and numerical scales : * Motivational factors * Self-evaluation of nutrition * Self-assessment of fatigue Part B: BEHAVIORAL INTERVENTION (10 weeks),the APA teacher will call a patient once a week for follow-up. Answer questionnaires and scales on the digital platform will be done : * Motivational factors * Self-evaluation of nutrition * Self-assessment of fatigue Part C : End of interventional phase(during 7 days) * measuring physical activity * complete questionnaires and numerical scales : * Motivational factors * Self-evaluation of nutrition * Self-assessment of fatigue

Study summary

Oncogeriatric: a collaboration between oncologists and geriatricians which aims to ensure that all elderly cancer patients receive treatment adapted to their condition, thanks to a multidisciplinary and multi-professional approach.

This project aims to gain a better understanding of the motivational determinants of PA and nutrition in elderly cancer patients.

It has a dual objective:

1. to identify clusters/groups in patients on the basis of daily motivational factors focusing on PA and nutrition
2. on the basis of the results obtained in (1), to propose an interventional study based on the previously established clusters, in order to examine the effects of a behavioral intervention on patients' adherence to PA and nutrition, both agreed according to an individualized goal and defined in agreement with the patient and the multidisciplinary team, taking into account the recommendations.

Eligibility

Sex
ALL
Min age
70 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Patient aged 70 or over 2. With cancer (solid tumors, all sites) 3. G8 ≤ 14 4. Inactive (patient not meeting recommended physical activity levels of 150 minutes per week at moderate intensity) 5. Patient has given informed, written and express consent 6. Patient affiliated to a French social security scheme. Exclusion Criteria: 1. Known presence of brain metastases 2. Inability to participate in digital platform assessments or physical tests 3. Inability to eat orally 4. Contraindication or inability to engage in physical activity 5. Patient unable to follow up regularly for psychological, family, numerical, social or geographical reasons 6. Person deprived of liberty or under protective custody or guardianship.

Primary outcome measure(s)

  • For observationnal phase : Identify relevant motivational levers in order to build a personalized and adapted behavioral intervention to improve physical activity and nutrition behaviors, via cluster analysis. — from baseline at 15 days
    Clusters (groups of patients) evaluated by the "silhouette coefficient" and seprated by behavior, on one hand concerning Physical Activity (PA) and on the other hand concerning nutrition.
  • For Interventionnal phase : Improving nutrition behaviors of elderly cancer patients — from baseline at 12 weeks
    Quality of nutrition questionnaire (Ingestas)
  • For Interventionnal phase : Improving physical activity behaviors of elderly cancer patients — from baseline at 12 weeks
    Number of physical activities

Trial sites (1)

FacilityCityRegionStatus
Institut Du Cancer de Montpellier Montpellier France Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06445140 on ClinicalTrials.gov ↗ ← All trials in France